HIRONIC, a pioneering Korean medical device manufacturer, has joined forces with Mastern America, the US subsidiary of Mastern Investment Management, in a strategic alliance aimed at strengthening their foothold in the competitive US market.
The partnership was formalized through the signing of a four-party memorandum of understanding involving HIRONIC, Mastern America, the city of Taylor, Texas, and the Taylor Economic Development Corporation (EDC). The signing ceremony, held at the prestigious JW Marriott Hotel Seoul, witnessed the presence of key stakeholders, including Sangwon Lee, CEO of HIRONIC; Joseph Oh, CEO of Mastern America; Brandt Rydell, Mayor of Taylor; and Ben White, CEO of Taylor EDC.
This agreement marks a strategic move for HIRONIC, known for its innovative skincare medical devices, as it aims to establish a production plant in Taylor, Texas. Mastern America, leveraging its expertise in real estate services, will play a pivotal role in providing support for various aspects of the project, including property acquisition, financing, development, construction management, and sales.
Taylor, located in close proximity to Austin, Texas, has emerged as a promising destination for high-tech ventures, owing to concerted efforts by local authorities and economic development entities like Taylor EDC. Tax incentives and other benefits will be provided to streamline the real estate development process for HIRONIC's expansion endeavors.
Sangwon Lee, CEO of HIRONIC, expressed gratitude for the partnership, highlighting the strategic advantages of setting up a production facility in the US, including enhanced access to North and South American markets and cost efficiencies in logistics. He also thanked Mayor Brandt Rydell and Ben White, CEO of Taylor EDC, for their unwavering support and collaboration throughout the negotiation process.
With HIRONIC's ambitious plans for expansion and Mastern America's commitment to facilitating this growth, the partnership between these two entities holds immense promise for driving innovation and delivering cutting-edge medical solutions in the dynamic US market.
HIRONIC Press Center
하이로닉 영문 웹사이트로 이동합니다.
글로벌 웹사이트에는 수출용 제품으로
대한민국에서 허가하지 않은 장비 및 서비스
내용을 포함하고 있습니다. 해당 내용은
대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC English website.
The Global Web Site contains equipment
and services that are not authorized by
the Republic of Korea These contents
are not subject to review and regulation
of medical devices in Korea.
하이로닉 EU 웹사이트로 이동합니다.
EU(Europe) 웹사이트의 내용은 "CE MDD 또는 CE MDR" 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
하이로닉 중국어 웹사이트로 이동합니다.
중국어 웹사이트에는 중국내 판매제품으로
대한민국에서 허가하지 않은 장비 및 서비스
내용을 포함하고 있습니다. 해당 내용은
대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.
正在移动到HIRONIC的中文官网。
在中问官网内介绍的产品只在中国销售的产品，
不一定是在韩国得到认可和服务内容。
针对这内容没有受到韩国医疗仪器广告审议限制。